Chimerix Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative antiviral drugs. With a focus on life-threatening viral infections, Chimerix aims to improve patient outcomes and address unmet medical needs. Through its research and development efforts, the company continues to advance its pipeline of potential therapeutics.